生命科学资讯

Clinician groups ask court to overturn CDC's childhood vaccine overhaul

Aspect Bio takes Novo castoff therapies; Takeda trims US jobs

Teladoc’s mental health arm BetterHelp has quietly expanded the use of AI

2025 ended on high note with a buoyant Q4 for M&A, PIPEs and follow-ons

J&J, Isomorphic sign research deal for AI-made molecules

GSK makes $2.2B deal for RAPT and its food allergy candidate

Exciva raises $59M Series B to fund Phase 2 test of Alzheimer’s agitation drug

JPM recap; Mirador raises $250M; Genentech’s PBM shift; and more

Agomab and SpyGlass file for IPOs as investor enthusiasm builds after JPM

AbbVie, Genmab say Epkinly didn't prolong overall survival in lymphoma study

Drugmakers without MFN pacts are bracing to make one

Supreme Court will hear Hikma’s ‘skinny label’ fight against Amarin

Makary talks FDA's plans to combat China's biotech growth

ImmunityBio's cell therapy posts encouraging early data in rare blood cancer

#JPM26: Sandoz CEO on Ozempic generic launch plans for 2026

European regulators recommended 38 novel drugs in 2025, 15 fewer than the FDA

Novo Nordisk, BioMarin make AI moves; Bristol Myers welcomes neurology exec from Eisai

New York sues ex-Emergent CEO over insider trading during vaccine manufacturing struggle

Trump asks Congress to codify ‘most favored nation’ deals